Hiroyoshi Koide

516 total citations
23 papers, 336 citations indexed

About

Hiroyoshi Koide is a scholar working on Oncology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Hiroyoshi Koide has authored 23 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Clinical Biochemistry and 4 papers in Molecular Biology. Recurrent topics in Hiroyoshi Koide's work include Metabolism and Genetic Disorders (5 papers), Amino Acid Enzymes and Metabolism (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Hiroyoshi Koide is often cited by papers focused on Metabolism and Genetic Disorders (5 papers), Amino Acid Enzymes and Metabolism (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Hiroyoshi Koide collaborates with scholars based in Japan. Hiroyoshi Koide's co-authors include Kayoko Saito, Toshiyuki Kumagai, Masatake Osawa, Kazuhiro Kobayashi, Tatsushi Toda, Junichi Sasaki, Eri Kondo-Iida, Yusuke Nakamura, Masao Watanabe and Kiyoshi Hayasaka and has published in prestigious journals such as PLoS ONE, Human Molecular Genetics and Drug Metabolism and Disposition.

In The Last Decade

Hiroyoshi Koide

23 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyoshi Koide Japan 7 156 96 48 38 35 23 336
Ruxiang Xu China 11 159 1.0× 48 0.5× 29 0.6× 37 1.0× 44 1.3× 18 346
Janusz Godlewski Poland 14 197 1.3× 122 1.3× 74 1.5× 24 0.6× 20 0.6× 54 544
Tailong Yi China 9 163 1.0× 54 0.6× 31 0.6× 22 0.6× 28 0.8× 14 347
Lili Xie China 12 168 1.1× 67 0.7× 48 1.0× 20 0.5× 40 1.1× 28 366
Guoqian He China 10 127 0.8× 32 0.3× 23 0.5× 14 0.4× 21 0.6× 33 313
Elisa Negri Italy 7 90 0.6× 32 0.3× 29 0.6× 29 0.8× 23 0.7× 15 360
Camila Araujo United States 11 211 1.4× 45 0.5× 38 0.8× 35 0.9× 183 5.2× 14 525
Yoichi Wada Japan 13 209 1.3× 74 0.8× 16 0.3× 43 1.1× 39 1.1× 27 372
Qin Fan China 11 133 0.9× 63 0.7× 24 0.5× 19 0.5× 14 0.4× 23 383

Countries citing papers authored by Hiroyoshi Koide

Since Specialization
Citations

This map shows the geographic impact of Hiroyoshi Koide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyoshi Koide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyoshi Koide more than expected).

Fields of papers citing papers by Hiroyoshi Koide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyoshi Koide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyoshi Koide. The network helps show where Hiroyoshi Koide may publish in the future.

Co-authorship network of co-authors of Hiroyoshi Koide

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyoshi Koide. A scholar is included among the top collaborators of Hiroyoshi Koide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyoshi Koide. Hiroyoshi Koide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sumimoto, Hidetoshi, Satoshi Noda, Hiroyoshi Koide, et al.. (2024). Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors. PLoS ONE. 19(7). e0306995–e0306995. 8 indexed citations
2.
Koide, Hiroyoshi, et al.. (2022). Analysis of Risk Factors for High-dose Cisplatin-induced Renal Impairment in Head and Neck Cancer Patients. In Vivo. 36(5). 2465–2472. 3 indexed citations
3.
Tsujimoto, Masayuki, Hiroyoshi Koide, Daiki Hira, et al.. (2021). In Vitro Evidence of Potential Interactions between CYP2C8 and Candesartan Acyl-β-D-glucuronide in the Liver. Drug Metabolism and Disposition. 49(4). 289–297. 4 indexed citations
4.
Hira, Daiki, Hiroyoshi Koide, Tomoyuki Okuda, et al.. (2021). Incorrect Holding Angle of Dry Powder Inhaler during the Drug-Loading Step Significantly Decreases Output Efficiency. Biological and Pharmaceutical Bulletin. 44(6). 822–829. 2 indexed citations
5.
Koide, Hiroyoshi, Satoshi Noda, Tetsuya Yoshida, et al.. (2021). Severe Skin Disorders Due to Sorafenib Use After Nivolumab Treatment in Renal Cell Carcinoma Patients. In Vivo. 35(5). 2969–2974. 3 indexed citations
6.
Hira, Daiki, Hiroyoshi Koide, Masafumi Yamaguchi, et al.. (2018). Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices. PLoS ONE. 13(2). e0193082–e0193082. 33 indexed citations
7.
Hira, Daiki, Masayuki Tsujimoto, Hiroyoshi Koide, et al.. (2018). Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia. International Journal of Clinical Pharmacology and Therapeutics. 56(7). 328–336. 2 indexed citations
8.
Koide, Hiroyoshi, et al.. (2018). Acceleration of carboxylesterase-mediated activation of irinotecan to SN-38 by serum from patients with end-stage kidney disease. Cancer Chemotherapy and Pharmacology. 81(6). 1121–1128. 4 indexed citations
9.
Tsujimoto, Masayuki, Hiroyoshi Koide, Kaori Ogawa, et al.. (2017). Cooperative inhibitory effects of uremic toxins and other serum components on OATP1B1-mediated transport of SN-38. Cancer Chemotherapy and Pharmacology. 79(4). 783–789. 17 indexed citations
10.
Koide, Hiroyoshi, Daiki Hira, Masayuki Tsujimoto, et al.. (2017). Previous Dosage of Allopurinol Is a Strong Determinant of Febuxostat Efficacy. Biological and Pharmaceutical Bulletin. 40(5). 681–686. 3 indexed citations
11.
Sasaki, Atsushi, Kei Shioda, Taku Homma, Ryo Fukatsu, & Hiroyoshi Koide. (2012). A 14‐year‐old girl with lissencephaly and craniofacial dysmorphism. Neuropathology. 32(6). 675–678. 1 indexed citations
12.
Abe, Akiko, Chikahiko Numakura, Kayoko Saito, et al.. (2009). Neurofilament light chain polypeptide gene mutations in Charcot–Marie–Tooth disease: nonsense mutation probably causes a recessive phenotype. Journal of Human Genetics. 54(2). 94–97. 77 indexed citations
13.
Kondo-Iida, Eri, Kazuhiro Kobayashi, Masao Watanabe, et al.. (1999). Novel Mutations and Genotype-Phenotype Relationships in 107 Families With Fukuyama-Type Congenital Muscular Dystrophy (FCMD). Human Molecular Genetics. 8(12). 2303–2309. 134 indexed citations
14.
Saito, Kayoko, Makiko Ōsawa, Yukio Fukuyama, et al.. (1998). CLINICAL FEATURES AND MOLECULAR GENETIC DIAGNOSIS OF PROXIMAL SPINAL MUSCULAR ATROPHY IN CHILDHOOD. 68(3). 93–107. 4 indexed citations
15.
Koide, Hiroyoshi, et al.. (1997). Idiopathic torsion dystonia and writing tremor within a family. Brain and Development. 19(8). 556–558. 9 indexed citations
16.
Koide, Hiroyoshi, et al.. (1993). West syndrome with cerebellar porencephalus. Journal of Intellectual Disability Research. 37(6). 569–576. 2 indexed citations
17.
Koide, Hiroyoshi, et al.. (1992). [Diagnosis, countermeasure and classification of acidosis].. PubMed. 50(9). 2146–51. 1 indexed citations
18.
Koide, Hiroyoshi, et al.. (1991). Characteristic changes on brain CT in a case of leigh encephalopathy with deficiency of pyruvate dehydrogenase. Brain and Development. 13(6). 457–458. 4 indexed citations
19.
Yamashita, Kazuya, et al.. (1991). [Effect of aging on P300 in normal subjects].. PubMed. 43(10). 945–50. 3 indexed citations
20.
Koide, Hiroyoshi. (1985). [Neuropathology of brainstem in severe cerebral palsy mainly due to perinatal asphyxia].. PubMed. 17(4). 293–300. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruxiang Xu Breakdown of academic impact, for papers by Janusz Godlewski Breakdown of academic impact, for papers by Tailong Yi Breakdown of academic impact, for papers by Lili Xie Breakdown of academic impact, for papers by Guoqian He Breakdown of academic impact, for papers by Elisa Negri Breakdown of academic impact, for papers by Camila Araujo Breakdown of academic impact, for papers by Yoichi Wada Breakdown of academic impact, for papers by Qin Fan
Rankless by CCL
2026